American International Group Inc. raised its stake in shares of Hill-Rom Holdings Inc (NYSE:HRC) by 4.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 114,856 shares of the medical technology company’s stock after buying an additional 4,905 shares during the period. American International Group Inc. owned approximately 0.18% of Hill-Rom Holdings worth $7,119,000 at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. Capstone Asset Management Co. raised its stake in shares of Hill-Rom Holdings by 4.2% in the second quarter. Capstone Asset Management Co. now owns 7,225 shares of the medical technology company’s stock worth $365,000 after buying an additional 290 shares during the period. Nordea Investment Management AB raised its stake in shares of Hill-Rom Holdings by 278.3% in the second quarter. Nordea Investment Management AB now owns 12,670 shares of the medical technology company’s stock worth $639,000 after buying an additional 9,321 shares during the period. IBM Retirement Fund raised its stake in shares of Hill-Rom Holdings by 16.4% in the second quarter. IBM Retirement Fund now owns 6,611 shares of the medical technology company’s stock worth $334,000 after buying an additional 931 shares during the period. LS Investment Advisors LLC raised its stake in shares of Hill-Rom Holdings by 67.4% in the second quarter. LS Investment Advisors LLC now owns 3,783 shares of the medical technology company’s stock worth $191,000 after buying an additional 1,523 shares during the period. Finally, Parametrica Management Ltd purchased a new stake in shares of Hill-Rom Holdings during the second quarter worth about $321,000. Institutional investors and hedge funds own 82.16% of the company’s stock.
Hill-Rom Holdings Inc (NYSE:HRC) traded down 0.34% during trading on Wednesday, reaching $58.43. 382,816 shares of the company’s stock were exchanged. Hill-Rom Holdings Inc has a 52 week low of $42.99 and a 52 week high of $63.12. The company’s 50 day moving average price is $55.69 and its 200-day moving average price is $56.35. The stock has a market capitalization of $3.84 billion, a price-to-earnings ratio of 31.41 and a beta of 1.15.
Hill-Rom Holdings (NYSE:HRC) last released its quarterly earnings results on Thursday, November 3rd. The medical technology company reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.13 by $0.05. Hill-Rom Holdings had a net margin of 4.67% and a return on equity of 18.93%. The company had revenue of $706 million for the quarter, compared to the consensus estimate of $701.39 million. During the same period in the previous year, the firm earned $0.89 EPS. Hill-Rom Holdings’s revenue was up 23.0% on a year-over-year basis. On average, equities analysts expect that Hill-Rom Holdings Inc will post $3.78 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, December 30th. Shareholders of record on Friday, December 16th were given a dividend of $0.17 per share. The ex-dividend date was Wednesday, December 14th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.16%. Hill-Rom Holdings’s dividend payout ratio (DPR) is 36.76%.
ILLEGAL ACTIVITY NOTICE: This article was first published by BBNS and is owned by of BBNS. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright law. The correct version of this article can be viewed at https://baseballnewssource.com/markets/american-international-group-inc-boosts-position-in-hill-rom-holdings-inc-hrc/344820.html.
Separately, Zacks Investment Research lowered shares of Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research report on Wednesday, October 5th.
In related news, COO Carlyn D. Solomon sold 40,515 shares of the business’s stock in a transaction that occurred on Thursday, November 17th. The shares were sold at an average price of $54.78, for a total value of $2,219,411.70. Following the sale, the chief operating officer now directly owns 22,163 shares in the company, valued at approximately $1,214,089.14. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 2.10% of the company’s stock.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.
Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with our FREE daily email newsletter.